Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide

Related Experiment Video

Updated: Oct 7, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

P Karle1, M Renner, B Salmons

  • 1Institute of Virology, University of Veterinary Sciences, Vienna, Austria.

Cancer Gene Therapy
|May 3, 2001
PubMed

Insights

This study reveals that cytochrome P450 2B1 (CYP2B1) expression in cells leads to a novel necrotic cell death mechanism when treated with ifosfamide (IFO). This finding impacts cancer gene therapy strategies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cytochrome P450 2B1 (CYP2B1) is an enzyme involved in drug metabolism.
  • Ifosfamide (IFO) is a prodrug used in cancer chemotherapy.
  • Suicide gene therapy aims to selectively kill cancer cells.

Purpose of the Study:

  • To investigate the mechanism of cell death induced by ifosfamide (IFO) in cells expressing cytochrome P450 2B1 (CYP2B1).
  • To explore the potential of CYP2B1/IFO suicide gene therapy for cancer treatment.

Main Methods:

  • Transfection of feline kidney cells with a vector overexpressing CYP2B1.
  • Assessment of cell viability and death mechanisms following IFO treatment.
  • Analysis of the diffusible nature of activated IFO metabolites.

Main Results:

  • CYP2B1-expressing cells demonstrated selective sensitivity to IFO.
  • Activated IFO metabolites exhibited a diffusible cell-killing effect on bystander cells.
  • IFO-induced cell death was confirmed to be necrotic, not apoptotic, challenging previous assumptions.
  • Phosphoramide mustard, an IFO metabolite, causes interstrand DNA cross-linking.

Conclusions:

  • The CYP2B1/IFO system induces cancer cell death via necrosis.
  • This necrotic mechanism has significant implications for immune system activation in cancer therapy.
  • The findings suggest a novel approach for enhancing the efficacy of CYP2B1/IFO suicide gene therapy.

More Related Videos

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c07:42

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c

Published on: June 29, 2011

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.